Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

This study has been completed.
Sponsor:
Collaborators:
other sponsors:Japanese MOPH
Labor and Welfare
Thai MOPH
Thai GPO
other collaborators: Bamrasnaradura Infectious Diseases Institute
Chiang Rai Hospital
King Chulalongkorn Memorial Hospital
Central General Chest Institute
The Research Institute of Tuberculosis (Japan)
Information provided by:
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT00476853
First received: May 20, 2007
Last updated: June 4, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
No publications provided by The HIV Netherlands Australia Thailand Research Collaboration

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):